Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The bad news is out and done with in 2018. Now let’s kick off 2019 with a bang at the JP Morgan conference!
Someone took out the teens, I’m curious to see if the seller reloads it. I’m guessing so as he or she seems to want out.
Ziv is done and we can finally put that behind us. Is the Kodiac lawsuit still out there? If that would go in our favor would more then offset what Ziv costed.
We can finally move forward with positive news to help our SP now.
Well, it would seem to me this group of sellers should be nearly out of shares. We shall see as we work our way through this weeks trading. I do still believe other factors have driven these investors to sell. Basically their selling is non company related.
I have to respectfully disagree with you on this one.
I’m not aware of another company moving their cream study into a phase 2 efficacy trial. Nor am I aware of another company moving their Sublingual tablet into a phase 2 efficacy trial for PTSD and Fibromyalgia.
Our Nasal spray animal safety study is to be complete this quarter, and I would assume with the 5 million dollar investor this could be heading to phase 1 human safety trial as early as Q1 2019.
This will result in 3 drugs, all in phase 2 efficacy in different stages in 2020. I have my core shares and will remain long because of this.
The big winner could ultimately be the MM study using a Parenteral delivery system. This also seems to be picking up speed since the 5 million dollar investor showed up.
When I was in Florida at the conference , I was told the cream study would take 18-24 months to complete because the study was expanded, and would keep expanding upon certain milestones, that was in February. We are now at the end of this timeline so I would assume it’s near completion. Did they do a poor job of explaining this to investors through Pr’s? Absolutely! Because I personally would’ve never known this without attending the conference.
With that being said, I’m amazingly confident in 2019 and beyond with this company. Efficacy trials is where it’s at to make money in a BioPharma company.
As always, I wish you and others the best of luck!
If it’s on their website I haven’t seen it. I would suspect an announcement anytime from the week before Christmas to just a few days before the event with a PR to follow.
I encourage some on here to look up the JP Morgan Conference. This is a pretty big deal to be invited to something like this. I know some are tired of more studies and more conferences, but this isn’t your average conference. Pfizer, Johnson&Johnson, etc. will be there. Many deals have been struck at or after this conference in the Healthcare industry.
OWCP is truly an unknown company. If it wasn’t for a silly thing called I-hub many of us wouldn’t even know OWCP existed. This conference could change that moving forward.
Best of luck and have an awesome weekend!
I think you’re safe to buy the dips right up til when and if the CSE is announced. After that it’s anyone’s guess where the Share price ends up. We have a very unique delivery system here, one that GWP$ might find interest in. I wouldn’t be afraid to tuck some shares away for the longterm.
Best of luck!
That’s a good amount of shares! I was hesitant about Alex Wasyl, but after listening to this guy talk, I’m now very confident in the company longterm. He’s intelligent and should be put in front of some institutional investors. I’m not sure what the future holds in the short term, but I don’t think you’ll get hurt at these levels buying if you’re willing to hold.
Cream phase 1 safety study near complete and going into phase 2 efficacy 2019.
Sublingual tablet phase 1 safety study complete in early to mid 2019 and going into phase 2 efficacy in 2019.
Nasal spray phase 1 safety human study starting in 2019.
MM study moving forward using a Parenteral delivery system, study is designed for orphan drug.
Yes, OWCP needs to finish just one of these studies. But at the end of the day, OWCP truly does have a lot going starting in 2019 and beyond!
I watched Hirsch speak at the Wall Street Conference last year. He was a good speaker and I would assume he would be the speaker at the JP Morgan conference addressing all these studies to a healthcare crowd. Their work will be valued much more at that conference then the Wall Street Conference.
Happy Friday and best of luck all!
I think these guys are on a much more aggressive path to get from point A to point B then our other company. I don’t know how long CSE will take, but I do understand it will open new doors up for large investors which the company needs.
I had a couple other investments do well recently, so I’m about ready to pull the trigger here myself.
I appreciate your input on both boards!
I think the fall could be unrelated. Very good chance it’s margin calls from other investments driving this as the stock market has tumbled. PP holders ultimately could double their original investment at .25 cents so they could be taking profits to pay the calls. As we work through this in the longterm it should begin to correct itself.
These guys seem committed to keeping shareholders informed. Good, longterm investment here with their unique delivery systems. GWP$ will probably show an interest in our epilepsy study, just IMO
Yeah, you’re only holding a bag if you don’t get your original investment back, plus a decent return you can be happy with. I’ve done that, and now I’m holding my longterm investment in a company that year over year has some pretty amazing potential, especially from these levels we are trading at.
I would like to buy more, but I stay disciplined in my investments and never hold more then I should of any one stock, no matter how great I think they are!
I learned this methodology from when an off branch of Enron wanted to build windmills on our farms in 2000. Thank god my father was a smart man and never signed that contract!
Sandy,
I agree that a phase 1 completion announcement at the J.P Morgan conference would be the companies goal. A forward looking announcement at that conference regarding the phase 2 study among other studies could be equally as important.
It’s all about the delivery system here! GWP$ epilepsy drug takes 3-4 months to take full effect. All of NXEN delivery systems are immediate. This is how the company separates itself from other other companies in this young industry. There is plenty to be excited about here in the short and longterm.
In my opinion, GWP$ will be watching this study closely! Lots of exciting things happening here!
I have asked about another PP possibly to invest in to raise money and I was told no. That was a couple months ago, so it would seem they are possibly looking at different avenues, or are maybe close to a funding deal?
It’s hard to know I guess until something is announced. I do know they’ve been working with the Israeli and United States Military to try and get a grant for for their nerve gas drug. So plenty of things to keep an eye on here moving forward.
I seen that to, but on the flip side this could run hard if shorts need to cover.
I agree, absolutely no bid support. Something is going to have to give here! Some volume is all we really need and it pops above .10 cents.
Yes, I 100 percent agree. I was told at the February conference with the intensity of this safety trial it would last 18 to 24 months from start to completion. We are at the end of that time frame now.
The multiple Mylomea study is one to keep an eye on also. The investor of 5 million is pushing for that to be accelerated since his investment.
Best wishes and have a happy Thanksgiving weekend!
The end of phase 1 I would think should be about complete. It's a 6 week program and with most subjects starting the trial immediately after the 8-k was announced and just a few a bit later. I have around a December completion figured and an immediate phase 2 ready to start. Proving efficacy in phase 2 will be a major catalyst for the company and stock holders.
I think I could write a book about I-hub and OWCP. Some of these posts! Lol
Moti and Miri were in Vegas. Miri takes care of partnerships now, so thank god she didn’t waste time talking to all these babbling people on here.
Amen to that!
Hopefully they spent their time talking with people more important then I- Hubbers.
I have just over 5% of that number going through the process of getting unrestricted. It’s important to note, PP holders like myself that are getting our shares unrestricted this late in the game really have no intention of selling much, if any stock. So as the float is rising a little, it really won’t mean a lot in the near term.
There seems to be a couple of PP holders who want their money back and are selling at these levels.Thats OK!!! It’s a healthy process that needs to happen when a stock starts trading. Ultimately, this is setting up nicely for a very strong run in the upcoming months! For now, buy the dips!
Happy Sunday and go Vikes!
Let me rephrase that:) although we typically are a blue state. We can personally be " conservative " with things like mmj.
Point is, midterm elections should help the MMJ movement as a whole! This will be a good stock to hold a core of shares long in!
This midterm election was important and one in my opinion that will help open doors to the legalization of marijuana for recreational and medical. We could see a shift that opens all the doors for medical use nationwide within a year from who all got elected. That's huge for patients and us stockholders!
If my conservative Minnesota wants in, it says a lot!
https://www.postbulletin.com/news/politics/ventura-talks-marijuana-legalization-with-walz/article_4ffa6b6e-e7af-11e8-b5be-e3f6ff72e3fb.amp.html
Yes, all that info came strait from the interview!
Sounds like they have a lot of announcements coming. More partners, patent applications, and exciting programs to announce in 2019. Sounds like more announcements through the holidays. They seem to really be pushing their drug delivery system for patents and proving how NXEN drugs can deliver an instant fix, rather then a drug delivery system like GWP$ does. Their drug takes 3.5 months to take full effect, whereas NXEN takes full effect immediately for epilepsy. Our nerve gas drug we know about works the same way for comparison.
I didn’t expect to check out this stock right now and see it this low, kinda surprised me! Seems like a pretty good buying opportunity to me.
I will pick some up this week at these levels. Most PP holders excersied their .38 cent warrants so I don't think there will much selling at or below that level. Basically I'm saying this is the bottom.:)
Can you post it please? I can't seem to find it.
Patent applications listed here also.
https://www.accesswire.com/526715/Nexien-BioPharma-Acquires-Princeton-Based-CRx-Bio-and-Announces-Additions-to-Senior-Management
Is that similiar to the route GWP$ took? It seems like they were even a penny stock at one time? I’m in the middle of a Vikings game or I would look it up! :)
I agree Zenguy! This is the most excited I’ve been about a stock since I was in OWC$. I’m long with my original investment, and will add as things remain quite here.
Good, factual article as always Feller! I haven’t researched the patent applications that came with this deal, have you?
That other stock is going to do what they should've done awhile ago which is add a professional PR /sales company or individuals to help that out. As for NXEN, these guys mean business and have it together. CSE and FDA news is highly possible in the next three months! Buy these dips if you're looking to add!
This guy will be good to have on board with us.
http://www.obermayer.com/attorneys/joseph-f-aceto/
Feller is right, there are a lot of PP people like myself that are still in the process of transferring shares. Mine as of today are still listed as restricted because I’m just getting the forms filled out to free them. I’m not in a hurry cause I’m not selling anyways. This thing has amazing short, but even more longterm potential.